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Background: Culturing of the sonication fluid of removed implants has proven to be more sensitive than
conventional periprosthetic tissue culture for the microbiological diagnosis of prosthetic joint infection. Since
bacteria surviving on antibiotic-loaded cement spacers used in a two-stage exchange protocol for infected
arthroplasties may cause the persistence of infection, in this study we asked whether the sonication also could be
used to identify bacteria on antibiotic-loaded cement spacers removed at the second surgical stage during a two-
stage exchange procedure to confirm whether or not the prosthetic joint infection had been eradicated.
Methods: We cultured the sonication fluid of cement spacers that had been originally implanted in a two-stage
exchange protocol in 21 patients (mean age, 66 years) affected by prosthetic joint infection (16 total knee
prostheses and 5 hip prostheses). The cement spacers were vortexed for 30 seconds and then subjected to
sonication (frequency 35–40 KHz). The resulting sonicate fluid was cultured for aerobic and anaerobic bacteria.
Results: The sonication fluid culture of the removed spacer was positive in six patients (29%), with isolation of
methicillin-sensible Staphylococcus Aureus (MSSA) in three cases, methicillin-resistant Staphylococcus Aureus
(MRSA) in one case and Pseudomonas Aeruginosa in two cases. In three of these positive cases, the traditional
culture of periprosthetic tissue was negative. Two patients with positive sonication culture of the spacer were
successfully treated by early debridement of the revision prosthesis and systemic antibiotic therapy. In three
patients a knee arthrodesis was planned and performed as the second surgical stage. In two of them the infection
was caused by highly resistant Pseudomonas Aeruginosa. The other patient with a MSSA infection had been poorly
compliant with the systemic antibiotic therapy due to her mental impairment. The patient originally affected by
MRSA infection of his primary hip arthroplasty developed recurrent infection of his revision prosthesis and
eventually underwent Girdlestone arthroplasty.
Conclusions: The sonication culture can be used to discover any bacteria on the antibiotic-loaded cement spacer
during a two-stage exchange protocol, thus permitting the adoption of timely treatment options, such as the early
prosthetic debridment.
Keywords: Prosthesis-related infections, Sonication, Bone cements, Treatment outcome, Microbial biofilm* Correspondence: maricond@unina.it
1Department of Orthopaedic Surgery, “Federico II” University, Policlinico
Federico II, Via S. Pansini 5, bd. 12, 80128, Naples, Italy
Full list of author information is available at the end of the article
© 2013 Mariconda et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
Mariconda et al. BMC Musculoskeletal Disorders 2013, 14:193 Page 2 of 8
http://www.biomedcentral.com/1471-2474/14/193Background
A two-stage exchange procedure is commonly used for
treating a prosthetic joint infection (PJI). It entails re-
moval of the prosthesis with debridement of all infected
tissue followed by administration of antimicrobial ther-
apy, and subsequent delayed reimplantation of a second
prosthesis. The temporary implantation of an antibiotic-
loaded cement spacer facilitates the ease and safeness of
the revision because it permits us to preserve the joint
space during the interim period and ensures local release
of antibiotics. High rates of satisfactory outcomes in
terms of infection eradication have been reported using
the two-stage exchange procedure [1], but in some cases
both the clinical picture and serum C-reactive protein
(CRP) levels do not normalize over time even with the
removal of the infected implant and the prolonged im-
plantation of the antibiotic-loaded cement spacer [2]. In
these cases, the presence of biofilm-forming pathogens
may cause the infection to persist and the antibiotic-
loaded cement itself can act as a biomaterial surface to
which bacteria may preferentially adhere, grow and pos-
sibly even develop antibiotic resistance [3]. Ultrasound
treatment may be used to dislodge biofilm bacteria from
the surface of orthopaedic implants allowing significant
recovery of microorganisms [4]. Culturing of the sonic-
ation fluid has proven to be more sensitive than conven-
tional periprosthetic tissue culture for the microbiological
diagnosis of PJI [5,6]. In this study we asked whether the
sonication also could be used to identify bacteria on
antibiotic-loaded cement spacers removed at the second
surgical stage during a two-stage exchange procedure, a)
to confirm whether or not the PJI had been eradicated
and b) to compare the findings from conventional intra-
operative tissue cultures with the findings after sonication
of the cement spacer.
Methods
From March 2009 to January 2011 we performed a two-
stage exchange procedure in 21 consecutive patients, 10
women and 11 men, affected by PJI (16 total knee pros-
theses and 5 hip prostheses). Mean patient age was
66.1 years (range, 55–78 years). The diagnosis of sus-
pected prosthetic infection was made on the basis of clin-
ical signs and symptoms (reported pain, hyperthermia,
swelling, redness), preoperative microbiological cultures
(material from joint aspiration or sinus track), laboratory
studies (leukocytosis, increased CRP), plain radiographs,
and nuclear medicine findings (99 m-Tc HMPAO labeled
leukocyte scan or 18-fluorodeoxyglucose positron emis-
sion tomography (FDG-PET) scan). To be included in this
study, that was approved by the institutional review board
of the Department of Surgery and Orthopaedics of
Federico II University, Naples, Italy and is compliant with
the Helsinki Declaration, all individuals gave their oraland written informed consent for the publication of indi-
vidual clinical details. They met at least one of the follow-
ing criteria to confirm the infection [7]: i) two or more
cultures of joint aspirates or cultures of intraoperative
specimens yielding the same microorganism; ii) purulence
surrounding the prosthesis at the time of explantation; iii)
acute inflammation consistent with infection during pa-
thohistological examination; iv) a sinus tract that commu-
nicated with the prosthesis. Removal of the prosthesis
with debridement of all infected tissue and placement of a
temporary molded antibiotic-loaded cement spacer was
performed in each case. All these spacers contained genta-
micin plus clindamycin, but in three cases an extra 2 g
vancomycin was added. At the time of the first surgical
stage, five specimens of periprosthetic tissue were intraop-
eratively collected under sterile conditions and sent for
microbiological and histopathological diagnosis. The pros-
thetic components were packed into sterile containers,
covered with four-hundred millilitres of Ringer’s solution,
and sent for sonication fluid analysis. The resection of
prosthetic components was followed by intravenously ad-
ministered empirical antibiotic treatment for one week
until the cultures and susceptibility tests were available.
Combination therapy including drugs showing activity
against biofilms was used on an outpatient basis thereafter,
according to the sensitivity profile of the cultured micro-
organisms. In 3 patients (14.3%) with negative pre- and
intra-operative cultures and positive histology showing
acute inflammation consistent with infection, an empirical
combination antibiotic treatment including rifampin was
given. The second surgical stage was performed after clin-
ical and laboratory findings had normalized. Antibiotic
therapy was discontinued at least two weeks before sur-
gery. The time interval between the removal of the
infected prosthesis and the reimplantation of the second
prosthesis varied, depending on the clinical and laboratory
response to antibiotics and the cultured microorganism
(Table 1). At the time of the cement spacer removal, mul-
tiple specimens of periprosthetic tissue were collected and
sent for microbiological and histopathological studies. The
cement spacers were packed into sterile containers, cov-
ered with four hundred millilitres of Ringer’s solution, and
sent for sonication. After the hospital discharge, patients
were checked clinically, serologically, and radiographically
at 2, 4, 12, and 24 weeks after the second surgery. There-
after, clinical, serologic (CRP, leukocyte count), and radio-
graphic checks were obtained every 6 months.Culture of tissue specimens
Tissue specimens were homogenized in 3 ml of brain-
heart-infusion broth for 1 min and the homogenate was
inoculated in aliquots of 0.5 ml. Aerobic and aerobic
sheep-blood agar were incubated at 35°C to 37°C in 5%
Table 1 Clinical, microbiological, and laboratory data for the 21 patients with prosthetic joint infection
Patient
No/Age,
Y/Sex
Prosthesis Medical
condition
Pre-operative
culture/
Microorganism
Pre-op
CRP mg/dl
Intra-
operative
culture (i)
Sonication
culture/
Prosthesis
Pre-2nd
stage CRP
mg/dl
Interim Period/
Second stage
surgery
Intra-
operative
culture (ii)
Sonication
culture/
Spacer
3rd stage surgery/
Follow-Up/Final
outcome
1/74/M TKA none joint aspiration
fluid/PA
1.0 no growth no growth 1.2 30 days/
reimplantation
no growth no growth none/28 months/no
recurrence
2/65/F TKA none joint aspiration
fluid/MSSA
1.8 MSSA MSSA 1.2 30 days/
reimplantation
no growth MSSA early debridement/
25 months/no recurrence
3/70/M TKA none culture of sinus
tract/ PA
2.5 PA PA 2.1 85 days/arthrodesis PA PA none/23 months/no
recurrence/bony fusion
4/68/M TKA none joint aspiration
fluid/CONS
2.8 CONS CONS 0.4 87 days/
reimplantation
no growth no growth none/25 months/no
recurrence
5/71/F TKA none joint aspiration
fluid/no growth
2.3 CONS CONS 0.3 90 days/
reimplantation
no growth no growth none/24 months/no
recurrence
6/70/M TKA none joint aspiration
fluid/no growth
30.0 CONS CONS 0.2 90 days/
reimplantation
no growth no growth none/28 months/no
recurrence
7/71/M TKA none joint aspiration
fluid/no growth
3.1 CONS CONS 0.3 92 days/
reimplantation
no growth no growth none/27 months/no
recurrence
8/78/M TKA none culture of sinus
tract/ PA
3.5 PA PA 1.0 92 days/ arthrodesis PA PA none/25 months/no
recurrence/fibrous union
9/72/M TKA none joint aspiration
fluid/CONS
4.1 CONS CONS 0.4 95 days/
reimplantation
no growth no growth none/27 months/no
recurrence
10/55/F THA none joint aspiration
fluid/no growth
3.5 MSSA MSSA 0.3 100 days/
reimplantation
no growth MSSA early debridement/
20 months/no recurrence
11/64/
M
TKA none joint aspiration
fluid/MSSA
1.8 MSSA MSSA 0.3 120 days/
reimplantation
no growth no growth none/26 months/no
recurrence
12/55/F TKA diabetes joint aspiration
fluid/no growth
0.3 MSSA CONS 0.3 120 days/
reimplantation
no growth no growth none/27 months/no
recurrence
13/62/F THA diabetes none 15.0 CONS CONS 0.3 125 days/
reimplantation
no growth no growth none/23 months/no
recurrence
14/64/F TKA none joint aspiration
fluid/no growth
1.9 no growth no growth 0.3 150 days/
reimplantation
no growth no growth none/23 months/no
recurrence
15/63/
M
TKA none joint aspiration
fluid/MSSA
2.0 MSSA none 1.7 150 days/
reimplantation
no growth no growth none/26 months/no
recurrence
16/68/
M
THA psoriasis culture of sinus
tract/MRSA
4.4 MRSA MRSA 0.4 180 days/
reimplantation
no growth MRSA Girdlestone
arthroplasty18 months/no
recurrence
17/58/F TKA schizophrenia culture of sinus
tract/ MSSA
0.5 CONS MSSA 0.7 180 days/
arthrodesis
MSSA MSSA none/24 months/no
recurrence/bony fusion
18/60/F THA none culture of sinus
tract/MSSA
30.0 MSSA MSSA 0.3 180 days/
reimplantation
no growth no growth none/26 months/no
recurrence
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Table 1 Clinical, microbiological, and laboratory data for the 21 patients with prosthetic joint infection (Continued)
19/66/
M
THA none none 5.8 CONS CONS 0.4 180 days/
reimplantation
no growth no growth none/22 months/no
recurrence
20/69/F TKA none joint aspiration
fluid/CONS
2.0 CONS CONS 0.5 210 days/
reimplantation
no growth no growth none/25 months/no
recurrence
21/64/F TKA none joint aspiration
fluid/no growth
1.8 no growth no growth 0.3 240 days/
reimplantation
no growth no growth none/29 months/no
recurrence
Abbreviations: CRP C-reactive protein, TKA total knee arthroplasty, THA total hip arthroplasty, MSSA methicillin-sensible Staphylococcus aureus, MRSA methicillin-resistant Staphylococcus aureus, CONS coagulase-negative
Staphylococcus, PA Pseudomonas Aeruginosa.
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http://www.biomedcentral.com/1471-2474/14/193to 7% carbon dioxide aerobically and anaerobically for
5 days and 7 days, respectively.
Sonication protocol
The container was vortexed for 30 seconds using a Vortex-
Genie (Scientific Industries, Inc, Bohemia, NY, USA) and
then subjected to sonication (frequency 35–40 KHz) in an
Aquasonic Model 750 T ultrasound bath (VWR Scientific
Products, Radnor, PA, USA) for 5 minutes, followed by
additional vortexing for 30 seconds. The resulting sonicate
fluid was plated in 500 μl aliquots onto aerobic Columbia
sheep blood agar plates for 5 days and anaerobic Shaedler
sheep blood agar for 7 days. Microorganisms were enu-
merated and classified by routine microbiological tech-
niques. A total of 200 ml of sonicate fluid was centrifuged
at 2600 rpm for 15 minutes and the sediment was gram
stained. All bacteria were counted and identified by
standard methods (VITEK Biomerieux, Bagno a Ripoli
(FI), Italy).
Statistical analysis
Continuous variables are expressed as the median and
interquartile range (IQR). Categorical variables were ana-
lyzed with a chi-squared test or Fisher’s exact test. P < 0.05
was considered statistically significant. SPSS software
(SPSS Inc., Chicago, Illinois, USA) was used for the data-
base and statistics.
Results
Table 1 presents the clinical and microbiological results
of the patients who underwent a two-stage procedure to
treat their PJI. The median length of the interim period
between the two surgical stages was 120 days (IQR 90 to
180) and the median length of follow-up after last surgi-
cal procedure was 25 months (IQR 23 to 27). At the
time of the second surgical stage, 18 patients underwent
a reimplantation procedure and the remaining 3 patients
received a knee arthrodesis. The sonication fluid culture
of the removed spacer was positive in six cases (29%)
and the traditional culture of the periprosthetic tissue
was positive in only three of these. In all cases with posi-
tive sonicate fluid culture of the removed spacer, the
same pathogen that had caused the initial infection grew
in the sonication culture of the cement spacer. In de-
tail (Table 1), we detected three methicillin-sensible
Staphylococcus aureus (MSSA), one methicillin-resistant
Staphylococcus aureus (MRSA), and two Pseudomonas
Aeruginosa infections. Two patients with MSSA infec-
tion (Table 1 – patients n. 2 and n. 10) of their spacer
were successfully treated by aggressive debridement of
the prosthetic joint within 30 days of prosthesis implan-
tation and systemic antibiotic therapy tailored to the
sensitivity of the cultures for 3 months. In three patients
a knee arthrodesis was planned and performed as thesecond surgical stage. Two of them with highly resistant
Pseudomonas Aeruginosa PJI (Table 1 – patients n. 3
and n. 8) did not respond to antibiotic therapy and
presented wound dehiscence and opening of a sinus
track. The third patient who received the knee arthrod-
esis was affected by MSSA infection (Table 1 – patient
n. 17) and had been poorly compliant with the systemic
antibiotic therapy due to her mental impairment. Both
the traditional intraoperative culture at the time of the
second surgical stage and the sonication culture of the
cement spacer in these three patients were positive. The
patient originally affected by MRSA infection of his
primary total hip arthroplasty (THA)(Table 1 – patient
n. 16) underwent removal of the infected prosthesis and
a gentamicin and clindamycin-loaded cement spacer
containing extra vancomycin was implanted. This pa-
tient firmly required to undergo implantation of a new
THA at the second surgical stage and because of the
complete normalization of clinical, laboratory, and nu-
clear medicine findings, a reimplantation was performed
180 days after the removal of the primary prosthesis.
Unexpectedly, MRSA was isolated by the sonication cul-
ture of his cement spacer. This patient developed recurrent
infection of his revision THA and eventually underwent
Girdlestone arthroplasty.
Discussion
Two-stage exchange is the standard in the treatment of
PJI. High frequency of success has been reported with
this strategy of management, with a rate of eradication
of both total knee arthroplasty [8] and THA [9] infec-
tion of more than 80 percent. Although not evaluated in
randomized controlled trials, the application of a tem-
porary antibiotic-loaded bone cement spacer in the in-
terim period before revision surgery is largely used in
the two-stage exchange protocol because it enables pres-
ervation of the joint space after removal of the primary
joint arthroplasty and ensures high local concentrations
of antibiotics that can help to eradicate the infection.
Despite the adoption of the two-stage exchange proto-
col, there are cases of persisting PJI where the cement
spacer itself may act as a biomaterial surface that facili-
tates survival of microorganisms [3,10]. Hence, it is of
paramount importance to actively look for biofilm bac-
teria on the removed cement spacer to determine whe-
ther the infection has been cleared. Nevertheless, the
limited sensitivity and specificity of standard microbio-
logical culture techniques may limit their ability to de-
tect the adherent bacteria responsible for PJI [11,12].
The application of ultrasound before culturing may dis-
rupt the biofilm from the surface of orthopaedic im-
plants and free the bacteria, enhancing the sensitivity of
traditional cultures [5,6]. In the present study we used
the sonication fluid culture of cement spacers to confirm
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exchange protocol. We are aware of only one recent
study that applied sonication culture to antibiotic-loaded
spacers to identify bacterial growth on the cement spa-
cer surface [13]. This study reported a 14.5% rate of
positive sonication fluid cultures of the removed spacer
and showed that an infection of the cement spacer is as-
sociated with poor clinical outcome. The sonicate fluid
culture of the removed spacer in our study was positive
in six cases (29%). In three of these positive cases, the
traditional culture of periprosthetic tissue failed to iden-
tify the pathogen. One notable difference with our re-
sults is that most sonication fluid cultures of the spacer
in the above cited study were discordant with the culture
of both the prosthesis (first-stage surgery) and peri-
prosthetic tissue specimens (second-stage surgery). If a
positive culture is obtained from the sonication process
that reveals the same bacteria that caused the initial PJI
as in the present study, it should be aggressively treated.
The idea would be that in these cases a one stage ex-
change had been performed and a regimen of prolonged
antibiotic therapy should be adopted.
Our results agree with the findings of other authors
who reported MSSA and MRSA on gentamicin-and
gentamicin-vancomycin-loaded cement beads, respect-
ively, using traditional cultures [3,14]. For patients in
whom pathogens are isolated on the cement spacer the
outcome should be guarded, particularly when the infec-
tion is sustained by highly resistant microorganisms.
Indeed, the patient with MRSA in this study developed
a recurrent infection even though a cement spacer
containing vancomycin had been used. The emergence
of resistance in bacterial strains is a concern about the
long-term exposure to antibiotics at the site of a pre-
vious infection [15]. In the case of MRSA infections,
the prolonged implantation of gentamicin/vancomycin-
loaded spacers may be associated with bacterial survival,
and hence with the persistence of infection [14], particu-
larly when an insufficient debridement has been carried
out at the time of explantation of the primary prosthesis.
Other studies have reported high failure rates after two-
stage reimplantation when the infection is sustained by
methicillin-resistant staphylococci [16-19]. In cases of
PJI sustained by highly virulent microorganisms for
which there is limited medical therapy, the arthrodesis
or resection arthroplasty may be a viable option as the
second stage surgery [20]. We performed a knee arth-
rodesis as the second surgical stage in three patients
who either failed to respond or were poorly compliant to
the antibiotic therapy. This proved to have been a fair
therapeutic choice because of the culture of both the son-
ication fluid and the periprosthetic tissue on samples col-
lected at the time of the second surgical stage which
showed persistence of the infection in these three patients.Some reservations must be stated with regard to the
interpretation of our results. One doubt emerging from
the present study is the practical usefulness of a diagnos-
tic test on the cement spacer carried out after the
reimplantation has already been performed. Even though
one previous in vivo study showed bacterial biofilm ad-
hesion to orthopaedic metals in the first 48 hours after
implantation [21], the reinfection of the reimplanted
prosthesis should be regarded and treated as an early in-
fection with a retention strategy, because bacterial adhe-
sion to the new implant and the biofilm formation have
not yet been fully realized. Indeed, our results and those
of previous studies [22-24] have demonstrated that pa-
tients with a short-term infection with a known patho-
gen and a stable implant may be successfully treated by
early debridement, with retention of the prosthesis and
the use of a standardized regimen of antimicrobial treat-
ment. The major limitation of this study is the small
sample size, which implies low statistical power. More-
over, although the mean duration of implantation of the
cement spacer between the two surgical procedures in a
two-stage protocol is highly variable in the literature, in
our study it was long and it could be questioned that the
long time that had elapsed between the two surgical
stages may have affected the bactericidal power of the
cement spacer and caused the growth of bacteria on its
surface [1]. Actually, the ability of cement spacers to en-
sure long-lasting bactericidal levels of antibiotics is con-
troversial. After one day, subinhibitory concentrations of
antibiotics on Staphylococcus aureus strains from differ-
ent cements have been detected in vitro [25] and a de-
clining trend over time in the antibiotic release from
cement spacers has been reported in vivo [26,27]. Con-
versely, other in vivo studies have shown that antibiotics
released from the spacers result in long lasting bacteri-
cidal concentrations in the peri-prosthetic tissue [15,28].
Individual variations in the local perfusion, the different
characteristics of the bone cement (porosity, roughness,
total surface area), and the method and doses adopted to
prepare the antibiotic-impregnated cement may lead to
a variable in vivo concentration and bioactivity of the
antibiotics released from the cement spacers and help to
explain the discrepancy between the published data
[15,27]. However, independent of the bactericidal power
of the cement spacer, positive clinical results have been
reported with long cycles of combined oral antibiotics
plus a delayed reimplantation in the two-stage exchange
protocol, even in infections sustained by highly resistant
bacteria [29].
Conclusions
Bacteria may survive on antibiotic-loaded cement spa-
cers, irrespective of the fact that they may have been
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the spacer. This might eventually result in a clinical re-
infection. The sonication culture is a complementary
method that can help to discover the possible persist-
ence of microorganisms on an antibiotic-loaded cement
spacer during a two-stage exchange protocol. Its use
may help to confirm whether an infection has been def-
initely cleared, or whether further therapeutic options,
such as the early debridment of the revision prosthesis,
are necessary. Our results emphasize the importance of
systemic antibiotics, given as a complement to the spa-
cer implantation.
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